Wells Fargo & Company Mannkind Corp Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Mannkind Corp stock. As of the latest transaction made, Wells Fargo & Company holds 434,630 shares of MNKD stock, worth $3.21 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

434,630

Previous 423,253 2.69%

Holding current value

$3.21 Million

Previous $1.92 Million 18.31%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$4.05 - $5.43 $46,076 - $61,777	11,377 Added 2.69%	434,630 $2.27 Million
Q1 2024 May 10, 2024	BUY	$3.25 - $5.27 $42,272 - $68,546	13,007 Added 3.17%	423,253 $1.92 Million
Q4 2023 Feb 09, 2024	SELL	$3.34 - $4.29 $92,958 - $119,399	-27,832 Reduced 6.35%	410,246 $1.49 Million
Q3 2023 Nov 13, 2023	SELL	$3.91 - $5.45 $17,004 - $23,702	-4,349 Reduced 0.98%	438,078 $1.81 Million
Q2 2023 Aug 15, 2023	SELL	$3.72 - $4.79 $748,891 - $964,298	-201,315 Reduced 31.27%	442,427 $1.8 Million
Q1 2023 May 12, 2023	BUY	$3.95 - $5.63 $1.16 Million - $1.65 Million	292,483 Added 83.27%	643,742 $2.64 Million
Q4 2022 Feb 13, 2023	SELL	$3.02 - $5.37 $62,752 - $111,583	-20,779 Reduced 5.59%	351,259 $1.85 Million
Q3 2022 Nov 14, 2022	BUY	$2.99 - $4.35 $14,337 - $20,858	4,795 Added 1.31%	372,038 $1.15 Million
Q2 2022 Aug 12, 2022	SELL	$2.67 - $4.77 $668,402 - $1.19 Million	-250,338 Reduced 40.54%	367,243 $1.4 Million
Q1 2022 May 16, 2022	SELL	$2.62 - $4.45 $252,127 - $428,232	-96,232 Reduced 13.48%	617,581 $2.27 Million
Q4 2021 Feb 14, 2022	SELL	$4.05 - $5.37 $965,228 - $1.28 Million	-238,328 Reduced 25.03%	713,813 $3.12 Million
Q3 2021 Nov 15, 2021	SELL	$3.89 - $5.48 $131,085 - $184,665	-33,698 Reduced 3.42%	952,141 $4.14 Million
Q2 2021 Aug 16, 2021	BUY	$3.61 - $5.45 $185,554 - $280,130	51,400 Added 5.5%	985,839 $5.37 Million
Q1 2021 May 13, 2021	BUY	$3.14 - $6.14 $1.05 Million - $2.05 Million	334,531 Added 55.76%	934,439 $3.66 Million
Q4 2020 Feb 09, 2021	SELL	$1.79 - $4.04 $61,287 - $138,325	-34,239 Reduced 5.4%	599,908 $1.88 Million
Q3 2020 Nov 05, 2020	BUY	$1.56 - $2.08 $202,940 - $270,587	130,090 Added 25.81%	634,147 $1.19 Million
Q2 2020 Aug 13, 2020	BUY	$0.94 - $2.21 $92,810 - $218,204	98,735 Added 24.36%	504,057 $883,000
Q1 2020 May 14, 2020	BUY	$0.84 - $1.76 $340,470 - $713,366	405,322 New	405,322 $417,000

Others Institutions Holding MNKD

# of Institutions

229

Shares Held

135M

Call Options Held

1.43M

Put Options Held

849K

View Full List

About MANNKIND CORP

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.9B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

More about MNKD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Mannkind Corp Transaction History